Gilead Sciences’ Innovative Approach To An HIV Clinical Trial Clinical Leader, 16 Dec 2021 By Moupali Das, MD, MPH, PrEP Clinical Program Lead, Gilead Sciences Prevention is the cornerstone of ending the HIV epidemic.